BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical Inc.verified

BMRN

Price:

$77.56

Market Cap:

$14.73B

BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria (PKU), an inherited metabolic disease. The company's commercial products also comprise Palynziq, a PEGylated recombinant phenylalanine ammonia lyase enzyme, which is delivered through subcu...[Read more]

Industry

Biotechnology

IPO Date

1999-07-26

Stock Exchange

NASDAQ

Ticker

BMRN

The PE Ratio as of May 2024 (TTM) for BioMarin Pharmaceutical Inc. (BMRN) is 73.17

According to BioMarin Pharmaceutical Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 73.17. This represents a change of -34.25% compared to the average of 111.29 of the last 4 quarters.

BioMarin Pharmaceutical Inc. (BMRN) Historical PE Ratio (quarterly & annually)

How has BMRN PE Ratio performed in the past?

The mean historical PE Ratio of BioMarin Pharmaceutical Inc. over the last ten years is -117.06. The current 73.17 PE Ratio has changed -6350.40% with respect to the historical average. Over the past ten years (40 quarters), BMRN's PE Ratio was at its highest in in the September 2014 quarter at 356.23. The PE Ratio was at its lowest in in the December 2022 quarter at -19329.36.

Quarterly (TTM)
Annual

Average

-117.06

Median

-97.92

Minimum

-634.76

Maximum

135.44

BioMarin Pharmaceutical Inc. (BMRN) PE Ratio by Quarter and Year

Discovering the peaks and valleys of BioMarin Pharmaceutical Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 509.07%

Maximum Annual PE Ratio = 135.44

Minimum Annual Increase = -1458.00%

Minimum Annual PE Ratio = -634.76

Quarterly (TTM)
Annual
YearPE RatioChange
2023108.03-20.24%
2022135.44-153.72%
2021-252.11-1458.00%
202018.56-102.92%
2019-634.76225.07%
2018-195.2746.94%
2017-132.89509.07%
2016-21.82-77.64%
2015-97.58-0.69%
2014-98.2678.81%

BioMarin Pharmaceutical Inc. (BMRN) Average PE Ratio

How has BMRN PE Ratio performed in the past?

The current PE Ratio of BioMarin Pharmaceutical Inc. (BMRN) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-2.88

5-year avg

-124.97

10-year avg

-117.06

BioMarin Pharmaceutical Inc. (BMRN) PE Ratio vs. Peers

How is BMRN’s PE Ratio compared to its peers?

BioMarin Pharmaceutical Inc.’s PE Ratio is greater than Seagen Inc. (-57.36), greater than Alnylam Pharmaceuticals, Inc. (-56.75), greater than Exelixis, Inc. (30.67), greater than Halozyme Therapeutics, Inc. (17.80), greater than Arrowhead Pharmaceuticals, Inc. (-6.49), greater than Incyte Corporation (17.20), greater than Ionis Pharmaceuticals, Inc. (-14.14), greater than Apellis Pharmaceuticals, Inc. (-12.17), greater than Vaxcyte, Inc. (-19.07), greater than Liquidia Corporation (-8.90), greater than Legend Biotech Corporation (-17.64), greater than Bio-Techne Corporation (64.94), greater than Mereo BioPharma Group plc (-63.73), greater than Blueprint Medicines Corporation (-22.42), greater than Agios Pharmaceuticals, Inc. (-5.49), greater than Day One Biopharmaceuticals, Inc. (-6.71), greater than IVERIC bio, Inc. (-33.43), greater than Amylyx Pharmaceuticals, Inc. (-1.75), greater than Karuna Therapeutics, Inc. (-29.52),

Build a custom stock screener for BioMarin Pharmaceutical Inc. (BMRN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like BioMarin Pharmaceutical Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

BioMarin Pharmaceutical Inc. (BMRN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like BioMarin Pharmaceutical Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is BioMarin Pharmaceutical Inc.'s PE Ratio?

How is the PE Ratio calculated for BioMarin Pharmaceutical Inc. (BMRN)?

What is the highest PE Ratio for BioMarin Pharmaceutical Inc. (BMRN)?

What is the 3-year average PE Ratio for BioMarin Pharmaceutical Inc. (BMRN)?

What is the 5-year average PE Ratio for BioMarin Pharmaceutical Inc. (BMRN)?

How does the current PE Ratio for BioMarin Pharmaceutical Inc. (BMRN) compare to its historical average?